Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
Sang Yi MoonYang Hyun BaekSe Young JangDae Won JunKi Tae YoonYoung Youn ChoHoon Gil JoAe Jeong JoPublished in: Gut and liver (2023)
Serum M2BPGi is a simple and effective test for advanced fibrosis in patients with NAFLD. Application of the two-step algorithm based on FIB-4 and M2BPGi proposed here can improve diagnostic performance and reduce unnecessary tests, making diagnosis easily accessible, especially in primary medical centers.